Table 3.
Item | AUC | Sensitivity | Specificity |
---|---|---|---|
Pre-op versus Healthy (hsa_circ_0006423) | 0.865 | 0.817 | 0.793 |
Pre-op versus Healthy (miR-492) | 0.883 | 0.817 | 0.842 |
Post-op versus Healthy (hsa_circ_0006423) | 0.766 | 0.744 | 0.707 |
Post-op versus Healthy (miR-492) | 0.694 | 0.451 | 0.927 |
Pre-op versus Post-op (hsa_circ_0006423) | 0.725 | 0.860 | 0.598 |
Pre-op versus Post-op (miR-492) | 0.767 | 0.573 | 0.866 |
Cancer versus Adjacent (hsa_circ_0006423) | 0.883 | 0.915 | 0.720 |
Cancer versus Adjacent (miR-492) | 0.954 | 0.890 | 0.866 |
Combination | 0.992 | 0.915 | 0.882 |
NSE | 0.619 | 0.733 | 0.567 |
CYFR21-1 | 0.586 | 0.633 | 0.633 |
CA72-4 | 0.521 | 0.867 | 0.367 |
NSE neuron-specific enolase, CYFR21-1 cytokeratin-19-fragment, CA72-4 cancer antigen 72-4.